IT AI in Oncology: Hype, Evidence, and the Threshold of Clinical Trust
Precision Signals Ep. 1
What does it take for AI to move from technical innovation to real-world adoption in oncology?
In the first episode of Precision Signals, a new podcast from the CEO Roundtable on Cancer, Dr. Sean Khozin speaks with Dr. Cora Sternberg and Dr. Olivier Elemento - two leaders at the intersection of clinical trials, precision medicine, and computational biology.
Together, they unpack the central paradox of medical AI: why so many tools are technically validated, yet so few are clinically trusted. Topics include:
This is a candid conversation about evidence, trust, and what it will take to build AI that earns a place in the oncology clinic, grounded in insights from the participants’ recent review published in NEJM AI: https://ai.nejm.org/doi/abs/10.1056/AIra2401164